GYRENasdaqPharmaceutical PreparationsFiscal year ends December 31
GYRE THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$6.09+0.01 (+0.16%)
Close on Oct 19, 2026
- Market cap
- $612.88M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Gyre Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 16, 2026 | Oct 22, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 1, 2026 | Sep 1, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 26, 2026 | Aug 26, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 7, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2026 | Aug 7, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 10, 2026 | Jul 16, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2026 | Jun 16, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 1, 2026 | Jun 2, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 8, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 4, 2026 | May 4, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 10, 2026 | Apr 27, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 22, 2026 | Mar 23, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 13, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2026 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 2, 2026 | Mar 2, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 5, 2026 | Jan 5, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 7, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2025 | Nov 7, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 10, 2025 | Sep 10, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 18, 2025 | Aug 22, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2025 | Jun 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 22, 2025 | May 23, 2025 | SEC EDGAR |
| Current report | 8-K | May 22, 2025 | May 22, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 9, 2025 | SEC EDGAR |
| Current report | 8-K | May 9, 2025 | May 9, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 28, 2025 | Apr 28, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 4, 2025 | Apr 21, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 17, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2025 | Mar 17, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 14, 2025 | Feb 18, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 31, 2024 | Jan 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 27, 2024 | Nov 27, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 13, 2024 | SEC EDGAR |